BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo W, Numata K, Morimoto M, Nozaki A, Nagano Y, Sugimori K, Zhou X, Tanaka K. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: Findings on hepatocellular carcinoma lesions. European Journal of Radiology 2009;72:425-31. [DOI: 10.1016/j.ejrad.2008.09.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo W, Numata K, Morimoto M, Oshima T, Ueda M, Okada M, Takebayashi S, Zhou X, Tanaka K. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma. Eur J Radiol. 2010;75:91-97. [PMID: 19361941 DOI: 10.1016/j.ejrad.2009.03.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
2 Arita J, Takahashi M, Hata S, Shindoh J, Beck Y, Sugawara Y, Hasegawa K, Kokudo N. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg. 2011;254:992-999. [PMID: 21694582 DOI: 10.1097/SLA.0b013e31822518be] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
3 Miwa H, Numata K, Sugimori K, Kaneko T, Sakamaki K, Ueda M, Fukuda H, Tanaka K, Maeda S. Differential diagnosis of solid pancreatic lesions using contrast-enhanced three-dimensional ultrasonography. Abdom Imaging 2014;39:988-99. [PMID: 24711063 DOI: 10.1007/s00261-014-0135-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
4 Numata K, Fukuda H, Miwa H, Ishii T, Moriya S, Kondo M, Nozaki A, Morimoto M, Okada M, Takebayashi S. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. Eur J Radiol. 2014;83:95-102. [PMID: 24176532 DOI: 10.1016/j.ejrad.2013.09.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
5 Alzaraa A, Gravante G, Chung WY, Al-Leswas D, Morgan B, Dennison A, Lloyd D. Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions. Hepatol Res 2013;43:809-19. [PMID: 23745715 DOI: 10.1111/hepr.12044] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
6 Kim J, Kim JH, Yoon SH, Choi WS, Kim YJ, Han JK, Choi B. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma. Ultrasound in Medicine & Biology 2015;41:3131-9. [DOI: 10.1016/j.ultrasmedbio.2015.07.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Cao J, Dong Y, Fan P, Mao F, Wang W. Feasibility of dynamic three-dimensional contrast-enhanced ultrasound in focal liver lesions: Image quality evaluation and correlation of quantification with two-dimensional contrast-enhanced ultrasound. CH 2019;72:305-16. [DOI: 10.3233/ch-180531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Li Q, Tang J, He E, Li Y, Zhou Y, Zhang X, Chen G. Clinical utility of three-dimensional contrast-enhanced ultrasound in the differentiation between noninvasive and invasive neoplasms of urinary bladder. European Journal of Radiology 2012;81:2936-42. [DOI: 10.1016/j.ejrad.2011.12.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
9 Luo W, Numata K, Morimoto M, Nozaki A, Ueda M, Kondo M, Morita S, Tanaka K. Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies. World J Gastroenterol 2010; 16(17): 2109-2119 [PMID: 20440851 DOI: 10.3748/wjg.v16.i17.2109] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
10 Nihonmatsu H, Numata K, Fukuda H, Tanaka K, Ooba M, Maeda S. Low mechanical index contrast mode versus high mechanical index contrast mode: which is a more sensitive method for detecting Sonazoid microbubbles in the liver of normal subjects? J Med Ultrasonics 2016;43:211-7. [DOI: 10.1007/s10396-015-0685-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Numata K, Luo W, Morimoto M, Kondo M, Kunishi Y, Sasaki T, Nozaki A, Tanaka K. Contrast enhanced ultrasound of hepatocellular carcinoma. World J Radiol 2010; 2(2): 68-82 [PMID: 21160920 DOI: 10.4329/wjr.v2.i2.68] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
12 Numata K, Fukuda H, Ohto M, Itou R, Nozaki A, Kondou M, Morimoto M, Karasawa E, Tanaka K. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. European Journal of Radiology 2010;75:e67-75. [DOI: 10.1016/j.ejrad.2009.11.022] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
13 Chan AK, Hegarty C, Klass D, Yoshida E, Chung S, Liu DM, Ho SG, Harris AC. The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma. Can Assoc Radiol J 2015;66:171-8. [DOI: 10.1016/j.carj.2014.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
14 Numata K. Advances in ultrasound systems for hepatic lesions in Japan. J Med Ultrason (2001) 2015;42:297-301. [PMID: 26576780 DOI: 10.1007/s10396-015-0630-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Fukuda H, Numata K, Hara K, Nozaki A, Kondo M, Chuma M, Nakano M, Nozawa A, Maeda S, Tanaka K. Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment. J Cancer 2018;9:2408-14. [PMID: 30026837 DOI: 10.7150/jca.24236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Wei S, Fu N, Yao C, Liu P, Yang B. Two- and three-dimensional contrast-enhanced sonography for assessment of renal tumor vasculature: preliminary observations. J Ultrasound Med 2013;32:429-37. [PMID: 23443183 DOI: 10.7863/jum.2013.32.3.429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Kunishi Y, Numata K, Morimoto M, Okada M, Kaneko T, Maeda S, Tanaka K. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. AJR Am J Roentgenol. 2012;198:106-114. [PMID: 22194485 DOI: 10.2214/ajr.10.6039] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 6.1] [Reference Citation Analysis]
18 Lee JY, Minami Y, Choi BI, Lee WJ, Chou YH, Jeong WK, Park MS, Kudo N, Lee MW, Kamata K, Iijima H, Kim SY, Numata K, Sugimoto K, Maruyama H, Sumino Y, Ogawa C, Kitano M, Joo I, Arita J, Liang JD, Lin HM, Nolsoe C, Gilja OH, Kudo M. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. Ultrasonography 2020;39:191-220. [PMID: 32447876 DOI: 10.14366/usg.20057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
19 Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. J Gastroenterol 2016;51:421-33. [PMID: 26694825 DOI: 10.1007/s00535-015-1151-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
20 Ohto M, Ito R, Soma N, Fukuda H, Shinohara Y, Sakamoto A, Kondo F. Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma. J Med Ultrason (2001) 2011;38:3-12. [PMID: 27278332 DOI: 10.1007/s10396-010-0283-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
21 Numata K, Fukuda H, Nihonmatsu H, Kondo M, Nozaki A, Chuma M, Morimoto M, Oshima T, Okada M, Murakami T, Takebayashi S, Maeda S, Inayama Y, Nakano M, Tanaka K. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease. Abdom Imaging 2015;40:2372-83. [PMID: 26099473 DOI: 10.1007/s00261-015-0489-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
22 El Kaffas A, Sigrist RMS, Fisher G, Bachawal S, Liau J, Wang H, Karanany A, Durot I, Rosenberg J, Hristov D, Willmann JK. Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases. Theranostics 2017;7:3745-58. [PMID: 29109773 DOI: 10.7150/thno.20329] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
23 Lee JY, Minami Y, Choi BI, Lee WJ, Chou YH, Jeong WK, Park MS, Kudo N, Lee MW, Kamata K, Iijima H, Kim SY, Numata K, Sugimoto K, Maruyama H, Sumino Y, Ogawa C, Kitano M, Joo I, Arita J, Liang JD, Lin HM, Nolsoe C, Gilja OH, Kudo M. The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. J Med Ultrasound 2020;28:59-82. [PMID: 32874864 DOI: 10.4103/JMU.JMU_124_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Miwa H, Numata K, Sugimori K, Sanga K, Hirotani A, Tezuka S, Goda Y, Irie K, Ishii T, Kaneko T, Tanaka K, Maeda S. Differential diagnosis of gallbladder polypoid lesions using contrast-enhanced ultrasound. Abdom Radiol (NY) 2019;44:1367-78. [PMID: 30478647 DOI: 10.1007/s00261-018-1833-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
25 Hoyt K, Sorace A, Saini R. Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound. Invest Radiol 2012;47:167-74. [PMID: 22104962 DOI: 10.1097/RLI.0b013e318234e6bc] [Cited by in Crossref: 59] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
26 Wang F, Numata K, Nihonmatsu H, Okada M, Maeda S. Application of new ultrasound techniques for focal liver lesions. J Med Ultrason (2001) 2020;47:215-37. [PMID: 31950396 DOI: 10.1007/s10396-019-01001-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]